Understanding the Neuroprotective Activities of Posiphen
Understanding the Neuroprotective Activities of Posiphen
批准号:
8573968
负责人:
KUMAR SAMBAMURTI
金额:
$22.43万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-07-15 至 2015-04-30
关键词:
5&apos Untranslated RegionsA MouseAgeAge-MonthsAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease riskAmyloidAmyloid beta-ProteinAmyloid beta-Protein PrecursorAmyloid depositionAmyloidosisAnimal ModelAnimalsBehaviorBioavailableBiological MarkersBiological PreservationBrainCanis familiarisCell Culture TechniquesCholinesterasesChromosomes, Human, Pair 16Chromosomes, Human, Pair 17Chromosomes, Human, Pair 21ClinicalClinical Drug DevelopmentCognitionDementiaDepositionDeteriorationDoseDown SyndromeDrug DesignDrug TargetingEventExhibitsFailureFutureGenetic TranslationGoalsHomeostasisHumanHuman ChromosomesHyperhomocysteinemiaImmunotherapyImpaired cognitionImpairmentIndividualInstitutesInterventionLesionLifeMeasuresMediatingMetabolic PathwayMethodsModelingMusMutationNerve DegenerationNeurodegenerative DisordersNeurofibrillary TanglesNeuronal DysfunctionNeuronsOral AdministrationPathogenesisPathologyPatientsPhase I Clinical TrialsPhenotypePlasmaPresenile Alzheimer DementiaPropertyProtein BiosynthesisProtein PrecursorsProteinsReducing AgentsRisk FactorsRodentRoleSenile PlaquesTartratesTestingTherapeuticTimeToxic effectTransgenic MiceTranslationsWeaningamyloid pathologybasal forebrain cholinergic neuronscholinergicfamilial Alzheimer diseasegamma secretasegrasphypercholesterolemiaimprovedmouse Ts65Dnmouse modelneuron lossneuropathologyneuroprotectionnovelphenserinepresenilinpreventprotein expressionpublic health relevancesecretasesmall moleculetau Proteinstheoriestool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Individuals with Down syndrome (DS) exhibit Alzheimer's disease (AD) neuropathology early in life, and develop progressive cognitive impairment in their fourth or fifth decade. Transgenic mice expressing Amyloid beta protein (A¿) precursor (APP) deposit amyloid but do not present degeneration phenotypes. A mouse model of DS, the Ts65Dn mice, suffers degeneration of a number of neuronal subtypes, including the basal forebrain cholinergic neurons that are lost in AD. This appears to require APP duplication although high APP is not sufficient to induce neurodegeneration in transgenic mice. We previously identified a novel compound - Posiphen - that inhibits APP translation by regulating the 5'-untranslated region of APP. We are planning to reduce APP expression by treating animal models with Posiphen to determine whether long-term treatment could arrent AD like pathology and if neurodegeneration in DS can be prevented by this treatment. The neurodegeneration in the TS65Dn mice appears to depend on APP making it a useful model to evaluate neuroprotection by anti-APP therapies. This R21 project will test the hypothesis that reduction of APP synthesis will restore homeostasis of this highly expressed protein and therefore prevent neuronal loss and behavior in DS mice. The second hypothesis is that Posiphen treatment will reduce amyloid accumulation as plaques. In future studies, we plan to continue collaborating with Dr. Nigel Greig for clinical development of the drug. The two specific aims of the project are: 1) Evaluate the effects of Posiphen treatment in the TS65Dn mice, which naturally express 1.5 times higher levels of APP and accumulate secreted APP derivatives with age; 2) Determine the effect of Posiphen on amyloid deposition in transgenic mouse models. We hypothesize that the treatment will successfully reduce neurodegeneration in the DS mouse model and provide us with the tools to identify the late and windows that may be targeted for intervention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dietary restriction and associated changes in gut microbiota to prevent Alzheimer disease
-
批准号:9905467
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2019
-
负责人:KUMAR SAMBAMURTI
-
依托单位:
Understanding the Neuroprotective Activities of Posiphen
-
批准号:8692627
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2013
-
负责人:KUMAR SAMBAMURTI
-
依托单位:
Regulation and Cell Biology of Beta-Secretase
-
批准号:6831156
-
项目类别:
-
资助金额:$23.94万
-
财政年份:2004
-
负责人:KUMAR SAMBAMURTI
-
依托单位:
Regulation and Cell Biology of Beta-Secretase
-
批准号:7446704
-
项目类别:
-
资助金额:$22.25万
-
财政年份:2004
-
负责人:KUMAR SAMBAMURTI
-
依托单位:
Regulation and Cell Biology of Beta-Secretase
-
批准号:6948204
-
项目类别:
-
资助金额:$23.94万
-
财政年份:2004
-
负责人:KUMAR SAMBAMURTI
-
依托单位:
Regulation and Cell Biology of Beta-Secretase
-
批准号:7090062
-
项目类别:
-
资助金额:$23.38万
-
财政年份:2004
-
负责人:KUMAR SAMBAMURTI
-
依托单位:
Regulation and Cell Biology of Beta-Secretase
-
批准号:7257057
-
项目类别:
-
资助金额:$22.7万
-
财政年份:2004
-
负责人:KUMAR SAMBAMURTI
-
依托单位:
Cholesterol and amyloidogenesis
-
批准号:7059414
-
项目类别:
-
资助金额:$35.41万
-
财政年份:2003
-
负责人:KUMAR SAMBAMURTI
-
依托单位:
Cholesterol and amyloidogenesis
-
批准号:7258826
-
项目类别:
-
资助金额:$34.38万
-
财政年份:2003
-
负责人:KUMAR SAMBAMURTI
-
依托单位:
NOVEL APPROACH FOR EXPRESSION CLONING OF APP SECRETASES
-
批准号:2408484
-
项目类别:
-
资助金额:$7.05万
-
财政年份:1997
-
负责人:KUMAR SAMBAMURTI
-
依托单位:
海外基金